[1]
M. Verma, S. Gupta, B. R. Bhagat, A. Mahajan, and B. Kaur, “Comparison of intravenous hydralazine and intravenous labetalol in the management of severe hypertensive disorders of pregnancy: a tertiary care centre study”, Int J Reprod Contracept Obstet Gynecol, vol. 7, no. 6, pp. 2251–2256, May 2018.